WO2012063262A2 - A novel intrauterine device with controlled copper release - Google Patents

A novel intrauterine device with controlled copper release Download PDF

Info

Publication number
WO2012063262A2
WO2012063262A2 PCT/IN2011/000770 IN2011000770W WO2012063262A2 WO 2012063262 A2 WO2012063262 A2 WO 2012063262A2 IN 2011000770 W IN2011000770 W IN 2011000770W WO 2012063262 A2 WO2012063262 A2 WO 2012063262A2
Authority
WO
WIPO (PCT)
Prior art keywords
copper
iud
biodegradable polymer
release
biodegradable
Prior art date
Application number
PCT/IN2011/000770
Other languages
French (fr)
Other versions
WO2012063262A3 (en
Inventor
Remya R. S
Abi Santhosh Aprem
Jeena Jose Karippal
Original Assignee
Hll Lifecare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hll Lifecare Limited filed Critical Hll Lifecare Limited
Priority to HU1300384A priority Critical patent/HU230345B1/en
Publication of WO2012063262A2 publication Critical patent/WO2012063262A2/en
Publication of WO2012063262A3 publication Critical patent/WO2012063262A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144Wirelike structures, e.g. loops, rings, spirals with T-configuration

Definitions

  • the invention relates generally to the field of contraceptive devices, particularly designed for intrauterine insertion.
  • the device of the present invention more specifically concerns with copper containing intrauterine device covered with a thin layer of a biodegradable polymer.
  • IUDs or intrauterine devices are a type of contraceptive medical device placed in the uterus. IUDs are safe and effective methods of long-term reversible contraception. Copper IUDs, which were first marketed in the early 1970s, represent an important contraceptive option for nearly 160 million women worldwide [1]. The design and copper content as well as placement of the copper on IUDs could affect their effectiveness and side effects. The presence of this foreign body in the uterus makes the endometrium to release leukocytes and prostaglandins. These substances are hostile to both sperm and eggs. It is reported that the presence of copper increases this spermicidal effect [2, 3].
  • the most widely used IUDs are copper-bearing IUDs (Cu-IUD).
  • Cu-IUD copper-bearing IUDs
  • the enhanced contraceptive effect of Cu-IUD is attributed to the copper ions released by the corrosion of copper in the uterus [4].
  • the contraceptive effectiveness of Cu-IUD is related to the surface area of copper on the device. Moreover they do not affect breastfeeding, interfere with intercourse, or have hormonal side effects.
  • the minimum amount of copper ions required for contraceptive action is 25-80 micrograms per day [5].
  • Cu-IUD The main limitation of Cu-IUD is their tendency to cause excessive pain and heavy menstrual bleeding in the initial days of insertion as a result of the burst release of copper ions into the uterus [6, 7]. This side effects decrease over time period [8]. Nevertheless the usage of Cu- IUDs is very less (except in Chine) owing to the above mentioned reason. In OOIndia, the government supports the Cu-T380A as the suitable IUD. The studies indicate that the copper ion release in 380A is much more compared to the other copper-bearing Ts like 220B and 220C, of course due to less amount of copper.
  • an Intra Uterine Ball (IUB) device comprising a hollow sleeve for at least partial insertion into the uterine cavity and an elongate conformable member comprised of shape memory alloy which is adapted to conform into a predetermined three dimensional ball - like configuration within the uterine cavity, with useful for a gynecological procedure or treatment has been disclosed.
  • IUB Intra Uterine Ball
  • degradable implantable medical device in the form of graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants, dental implants and spinal disks.
  • the present invention speaks about coating the copper bearing IUD with a polymer which is biocompatible and regulate the release of Cu 2+ ions in such a way to ensure the concentration required for contraception.
  • the present invention relates to intrauterine devices and more specifically concerns with copper containing intrauterine device covered with a thin layer of a biodegradable/bioabsorbable polymer, which degrade over a clinically relevant period of time, to minimize the burst release of copper ions. Due to coating, biodegradable/bioabsorbable polymer thin film according to the present invention can prevent
  • the copper ions from being excessively released in the early stage immediately after insertion, which contributes, to bleeding and pain, and after that, can gradually release the copper ions over a delayed period as the biodegradable/bioabsorbable polymer thin layer is degraded.
  • the polymer thin layer degrades in the uterus environment within a clinically relevant time period, such as approximately fifteen days to five month.
  • the device may have at least a portion which degrades at a controlled degradation rate to approximate dissolution at or within one month.
  • the biodegradable/bioabsorbable polymer is one or more compounds selected from the group 1 15 consisting of poiyglycolide (PGA), polylactide (PLA), poly caprolactone (PCL), and their copolymers, derivatives and copolymers of poly(amino acid), polyanhydride and polyorthoesters, , PVA (polyvinyl alcohol)chitosan or their blends or composites.
  • the biodegradable/bioabsorbable polymer has a weight-average molecular weight ranging from about 100 g/mol to about 1,000,000 g/mol.
  • the thickness of the biodegradable/ bioabsorbable 120 polymer coating is from about 10 ⁇ to about 10mm.
  • Degradation of the polymer thin layer may occur in multiple phases, such as a slower degradation rate in one phase and a faster degradation rate in another phase or in the reverse order.
  • the biodegradable polymer coated copper-T will release copper ions to the 125 surrounding aqueous medium at a release rate of 10 to 100 micrograms of copper ions per day. Therefore, the coated copper-T of the present invention can be effectively used for controlled copper ion release for contraception.
  • FIG. 1 is the graph to illustrate the variation of Cu 2 + release rate for polymer coated Cu-T380 A and uncoated Cu-T 380A in simulated uterine solution (SUS) for a period of 10 months
  • the present invention provides a new and improved reversible contraceptive copper bearing intrauterine device, comprising of a biodegradable/bioabsorbable thin film coated copper- T.
  • the purpose of using this thin film coated copper-T is to control and minimize the burst release of copper ions after the insertion of the device in the uterine environment.
  • biodegradable thin film coated in the IUD reduces the copper ions release rate during the early stage. Another advantageous effect of the present invention, while reducing the burst release of copper ions, it avoids over bleeding and pain which may usually occur in conventional intrauterine devices. As the biodegradable/bioabsorbable polymer thin layer is degraded over time, it renders gradual release of the copper ions. Degradation of the polymer
  • thin layer may occur in multiple phases, such as a slower degradation rate in one phase and a faster degradation rate in another phase or in the reverse order.
  • the biodegradable/bioabsorbable polymer according to the invention is a non erodible polymer selected from one or more compounds of a group consisting of polyglycolide (PGA), 150 polylactide (PLA), poly caprolactone (PCL), and their copolymers, derivatives and copolymers of poly (amino acid), polyanhydride and polyorthoesters, PVA (polyvinyl alcohol) chitosan or their blends or composites at different proportions/ratios.
  • PGA polyglycolide
  • PLA polylactide
  • PCL poly caprolactone
  • the biodegradable/bioabsorbable 155 polymer selected has a weight-average molecular weight ranging from about 100 g/mol to about 1,000,000 g/mol and the organic solvent is selected from the group consisting of tetrahydrofuran, methylene chloride, chloroform, ethyl acetate, hexafluoroisopropanol and acetone and their combinations.
  • the biodegradable/bioabsorbable polymer is used in an amount of about 5 wt % to about 75 wt % based on the weight of the organic solvent.
  • the thickness of the biodegradable/ bioabsorbable polymer coating varies between 10 ⁇ ⁇ to about 10 mm.
  • the biodegradable/bioabsorbable polymer coated copper-T will release copper ions to the surrounding aqueous medium at a release rate variable within a range of 10 to 100 165 micrograms of copper ions per day.
  • the biodegradable polymer coated copper-T can avoid the excessive release of copper ions immediately after insertion and will gradually release the copper ions over a delayed period as the biodegradable/bioabsorbable polymer thin layer is degraded.
  • the polymer thin layer degrades in the uterus environment within a clinically relevant time period, such as approximately fifteen days to five month.
  • the devices at least partially degrade in the uterus environment in less than one week, such as a few days, one day, a few hours, one hour or less.
  • the device may have at least a portion which degrades at a controlled degradation rate to approximate dissolution at or within one month.
  • the biodegradable/ bioabsorbable polymer coated copper-T will release copper ions to the surrounding aqueous medium at a uniform release rate, which is required for providing contraception.
  • the biodegradable/bioabsorbable polymer coated copper-T will be beneficial since there is no side effect arising from bulk release of copper ions.
  • the IUD of the present 180 invention is made of polyethylene frame over which the copper releasing units are present.
  • the insertion method of biodegradable/ bioabsorbable polymer coated copper-T is the same as such for uncoated Cu-T insertion.
  • the IUD member in its three dimensional configuration has a diameter which is significantly higher than the diameter of the cervical canal thereby 185 expulsion of IUD member from the uterine cavity is prevented.

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A novel intrauterine contraceptive device of the present invention is developed to surmount the problem prevailing with the conventional contraceptive device. The IUD of the present invention is covered with a thin layer of a biodegradable/bioabsorbable polymer, to control the excessive release of copper ion in the early stage and to minimize bleeding and pain after insertion. The polymer thin layer has a controlled degradation rate and advantageously degrades over a period of time say between one month and five month in the uterus environment.

Description

A NOVEL INTRAUTERINE DEVICE WITH CONTROLLED COPPER RELEASE
FIELD OF INVENTION; The invention relates generally to the field of contraceptive devices, particularly designed for intrauterine insertion. The device of the present invention more specifically concerns with copper containing intrauterine device covered with a thin layer of a biodegradable polymer. BACKGROUND OF THE INVENTION:
IUDs or intrauterine devices are a type of contraceptive medical device placed in the uterus. IUDs are safe and effective methods of long-term reversible contraception. Copper IUDs, which were first marketed in the early 1970s, represent an important contraceptive option for nearly 160 million women worldwide [1]. The design and copper content as well as placement of the copper on IUDs could affect their effectiveness and side effects. The presence of this foreign body in the uterus makes the endometrium to release leukocytes and prostaglandins. These substances are hostile to both sperm and eggs. It is reported that the presence of copper increases this spermicidal effect [2, 3].
The most widely used IUDs are copper-bearing IUDs (Cu-IUD). The enhanced contraceptive effect of Cu-IUD is attributed to the copper ions released by the corrosion of copper in the uterus [4]. The contraceptive effectiveness of Cu-IUD is related to the surface area of copper on the device. Moreover they do not affect breastfeeding, interfere with intercourse, or have hormonal side effects. The minimum amount of copper ions required for contraceptive action is 25-80 micrograms per day [5].
The main limitation of Cu-IUD is their tendency to cause excessive pain and heavy menstrual bleeding in the initial days of insertion as a result of the burst release of copper ions into the uterus [6, 7]. This side effects decrease over time period [8]. Nevertheless the usage of Cu- IUDs is very less (except in Chine) owing to the above mentioned reason. In OOIndia, the government supports the Cu-T380A as the suitable IUD. The studies indicate that the copper ion release in 380A is much more compared to the other copper-bearing Ts like 220B and 220C, of course due to less amount of copper.
In WO Patent No 2010082197 dated July 22, 2010, an Intra Uterine Ball (IUB) device comprising a hollow sleeve for at least partial insertion into the uterine cavity and an elongate conformable member comprised of shape memory alloy which is adapted to conform into a predetermined three dimensional ball - like configuration within the uterine cavity, with useful for a gynecological procedure or treatment has been disclosed. In the Journal of Biomedical materials Research Part B: Applied Biomaterials, Vol. 80B, Issue 1, 220-225 (2006), the Cu2+ release rate of nano and micro copper/low density polyethylene as an intrauterine device in the uterine solution was disclosed. Both types of composites exhibited burst release behavior of Cu2+ within the first month of incubation, but nanocomposites showed steady release of Cu2+ ions.
In an article presented in the journal Contraception 70 (2004) 153-157, nanocopper/low density polyethylenes as a potential copper carrier in IUDs have been reported. The composite offered a reduction in large initial release of Cu2+ ions provided with continuous release in amounts effective for contraception.
In WIPO Patent No. WO/2006/108065, disclosure is made on degradable implantable medical device in the form of graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants, dental implants and spinal disks.
In European Patent No. NL 1024660 (C2), a copper containing carrier with a coating that releases a hemostatic agent has been reported. An independent claim of this patent discloses the production of the device which includes partial insertion of the carrier into a container containing the hemostatic agent, removal of the carrier from the container and fixing the hemostatic agent to the carrier. Taking into consideration of all the above facts, the researchers have tried to develop newer varieties of IUDs over the period of time. The non-acceptance of the copper-bearing IUDs due to the bulk release of copper ions (100-150micrograms per day) in the initial days after insertion can be overcome by controlling the release rate by suitable means. In all the conventional system and prior art, the contraceptive intrauterine device does not disclose on the use of any biodegradable polymer coating over the device.
The present invention speaks about coating the copper bearing IUD with a polymer which is biocompatible and regulate the release of Cu2+ ions in such a way to ensure the concentration required for contraception.
References:
1. "The intrauterine device (IUD)-worth singing about". World Health Organization (2002). Progress in Reproductive Health Research (60): 1-8.
2. "Mechanisms of the Contraceptive Action of Hormonal Methods and Intrauterine Devices (IUDs)". Family Health International, 2006. 3. Keller, Sarah (Winter 1996, Vol. 16, No. 2). "IUDs Block Fertilization". Network.
Family Health International.
4. Jianjun Zhu, Naixin Xu, Chengdian Zhang, "Characterestics of copper corrosion in simulated uterine fluid in the presence of protein", Advances in contraception, 15: 179-190, 1999.
5. Kjaer A, Laursen K, Thormann L, Borggard O, Lebech P. E, "Copper released from copper intrauterine devices, removed after up to 8 years of use, Contraception, 47: 349-358, 1993
6. Timonen H, "Copper release from copper-T interauterine devices", Contraception, 14 (1): 25-38, 1976
7. Zielske H, Koch U J, Badura R, Ladeburg H, "Studies on copper release from copper- T device (T-Cu200) and its influence on sperm migration in vitro", Contraception, 10:651 -656, 1974
8. David Hubacher, Pai-Lien Chen, Sola Park, "Side effects from the copper IUD: do they decrease over time?" Contraception, 79: 356-362, 2009
SUMMARY OF THE INVENTION
100 The present invention relates to intrauterine devices and more specifically concerns with copper containing intrauterine device covered with a thin layer of a biodegradable/bioabsorbable polymer, which degrade over a clinically relevant period of time, to minimize the burst release of copper ions. Due to coating, biodegradable/bioabsorbable polymer thin film according to the present invention can prevent
105 the copper ions from being excessively released in the early stage immediately after insertion, which contributes, to bleeding and pain, and after that, can gradually release the copper ions over a delayed period as the biodegradable/bioabsorbable polymer thin layer is degraded. The polymer thin layer degrades in the uterus environment within a clinically relevant time period, such as approximately fifteen days to five month. The devices at least partially
1 10 degrade in the uterus environment in less than one week, such as a few days, one day, a few hours, one hour or less. For example, the device may have at least a portion which degrades at a controlled degradation rate to approximate dissolution at or within one month.
The biodegradable/bioabsorbable polymer is one or more compounds selected from the group 1 15 consisting of poiyglycolide (PGA), polylactide (PLA), poly caprolactone (PCL), and their copolymers, derivatives and copolymers of poly(amino acid), polyanhydride and polyorthoesters, , PVA (polyvinyl alcohol)chitosan or their blends or composites. The biodegradable/bioabsorbable polymer has a weight-average molecular weight ranging from about 100 g/mol to about 1,000,000 g/mol. The thickness of the biodegradable/ bioabsorbable 120 polymer coating is from about 10 μιη to about 10mm.
Degradation of the polymer thin layer may occur in multiple phases, such as a slower degradation rate in one phase and a faster degradation rate in another phase or in the reverse order. The biodegradable polymer coated copper-T will release copper ions to the 125 surrounding aqueous medium at a release rate of 10 to 100 micrograms of copper ions per day. Therefore, the coated copper-T of the present invention can be effectively used for controlled copper ion release for contraception.
BRIEF DESCRIPTION OF THE DRAWINGS
130
FIG. 1 is the graph to illustrate the variation of Cu2+ release rate for polymer coated Cu-T380 A and uncoated Cu-T 380A in simulated uterine solution (SUS) for a period of 10 months
DESCRIPTION OF THE INVENTION;
135
The present invention provides a new and improved reversible contraceptive copper bearing intrauterine device, comprising of a biodegradable/bioabsorbable thin film coated copper- T. The purpose of using this thin film coated copper-T is to control and minimize the burst release of copper ions after the insertion of the device in the uterine environment. The
140 biodegradable thin film coated in the IUD reduces the copper ions release rate during the early stage. Another advantageous effect of the present invention, while reducing the burst release of copper ions, it avoids over bleeding and pain which may usually occur in conventional intrauterine devices. As the biodegradable/bioabsorbable polymer thin layer is degraded over time, it renders gradual release of the copper ions. Degradation of the polymer
145 thin layer may occur in multiple phases, such as a slower degradation rate in one phase and a faster degradation rate in another phase or in the reverse order.
The biodegradable/bioabsorbable polymer according to the invention, is a non erodible polymer selected from one or more compounds of a group consisting of polyglycolide (PGA), 150 polylactide (PLA), poly caprolactone (PCL), and their copolymers, derivatives and copolymers of poly (amino acid), polyanhydride and polyorthoesters, PVA (polyvinyl alcohol) chitosan or their blends or composites at different proportions/ratios.
According to another embodiment of the present invention, the biodegradable/bioabsorbable 155 polymer selected has a weight-average molecular weight ranging from about 100 g/mol to about 1,000,000 g/mol and the organic solvent is selected from the group consisting of tetrahydrofuran, methylene chloride, chloroform, ethyl acetate, hexafluoroisopropanol and acetone and their combinations.
160 The biodegradable/bioabsorbable polymer is used in an amount of about 5 wt % to about 75 wt % based on the weight of the organic solvent. The thickness of the biodegradable/ bioabsorbable polymer coating varies between 10 μ ι to about 10 mm. The biodegradable/bioabsorbable polymer coated copper-T will release copper ions to the surrounding aqueous medium at a release rate variable within a range of 10 to 100 165 micrograms of copper ions per day. The biodegradable polymer coated copper-T can avoid the excessive release of copper ions immediately after insertion and will gradually release the copper ions over a delayed period as the biodegradable/bioabsorbable polymer thin layer is degraded.
170 The polymer thin layer degrades in the uterus environment within a clinically relevant time period, such as approximately fifteen days to five month. The devices at least partially degrade in the uterus environment in less than one week, such as a few days, one day, a few hours, one hour or less. For example, the device may have at least a portion which degrades at a controlled degradation rate to approximate dissolution at or within one month.
175
The biodegradable/ bioabsorbable polymer coated copper-T will release copper ions to the surrounding aqueous medium at a uniform release rate, which is required for providing contraception. The biodegradable/bioabsorbable polymer coated copper-T will be beneficial since there is no side effect arising from bulk release of copper ions. The IUD of the present 180 invention is made of polyethylene frame over which the copper releasing units are present.
The insertion method of biodegradable/ bioabsorbable polymer coated copper-T is the same as such for uncoated Cu-T insertion. The IUD member in its three dimensional configuration has a diameter which is significantly higher than the diameter of the cervical canal thereby 185 expulsion of IUD member from the uterine cavity is prevented.
Initial studies were conducted by coating the stem of Cu-T 380 A with pol (lactide-co- glycolide) in ethyl acetate. For the determination of Cu2+ ion release from the device, both the uncoated Cu-T 380A and coated Cu-T 380A of the present invention were suspended and
190 incubated in 50 ml simulated uterine solution (SUS) at temperature of 30 +/- 10°C. The variation of Cu2+ release in SUS for both the devices is shown in figure 1. It can be seen that the initial copper release from coated Cu-T 380A is around 58 microgram/day and that of Cu- T 380A is around 114 microgram/day. Table 1 shows the release of Cu2+ for coated and uncoated Cu-T 380 A. Thus the copper release from the device of the present invention is
195 very less which makes the users comfortable.
Table 1 : Cu2+ release for coated Cu-T 380A and uncoated Cu-T380 A
Time Period Concentration of Sample
Coated Cu T Uncoated Cu T
After 24 hours 40 195
After 7 days 42 190
After 15 days 45 168
After 30 days 51 165
After 45 days 55 143
After 2 months 63 138 After 3 months 75 127
After 4 months 52 112
After 5 months 54 83
After 6 months 62 74
After 7 months 61 68
After 8 months 67 49
After 9 months 68 47
After 10 months 70 46
200 Toxicology studies have proven that the new system is not cytotoxic. Preclinical evaluation studies such as Genotoxicity, Acute systemic toxicity, Hemolytic property, Sensitization tests and implantation tests are conducted to prove safety of the device and obtained positive results
205 While the foregoing written description of the invention enables one of ordinary skill to make and use what is considered presently to be the best mode thereof, those of ordinary skill will understand and appreciate the existence of variations, combinations, and equivalents of the specific embodiment, method, and examples herein. The invention should therefore not be limited by the above described embodiment, method, and examples, but by all embodiments
210 and methods within the scope and spirit of the invention as claimed

Claims

WE CLAIM
215 1. A novel intrauterine device (IUD) adaptable to insertion in the uterine cavity for the controlled release of copper ions comprising a copper- T coated with a thin layer of a biodegradable / bioabsorbable polymer
2. The IUD of claim 1, is made of polyethylene frame over which the copper releasing 220 units are present
3. The IUD according to claim 1, wherein said biodegradable polymer coated copper-T avoids the excessive release of copper ions immediately after insertion of said IUD in the uterus environment
225
The IUD according to claim 1, gradually releases the copper ions over a delayed period as the said biodegradable polymer thin layer is degraded
5. The IUD according to claim 1 , wherein the said biodegradable polymer coated
230 copper-T releases copper ions at a uniform release rate required for providing contraception
6. The IUD of claim 1, has no side effect arising from bulk release of copper ions such that the use of said biodegradable polymer coated copper-T will be beneficial.
235
7. The IUD according to claim 1, member in its three dimensional configuration has a diameter which is significantly higher than the diameter of the cervical canal such that the expulsion of said member from said uterine cavity is prevented
240 8. A method of preparing biodegradable thin film coated copper- T comprising:
dissolving biodegradable polymer in an organic solvent, to prepare a thin film coat over the copper-T using the said biodegradable polymer for the controlled release of copper ions
245 9. The biodegradable polymer according to claim 8; is one or more compounds selected from the group consisting of polyglycolide (PGA), polylactide (PLA), poly(lactide- glycolide) copolymer (PLGA), poly caprolactone (PCL), poly(lactide- □- caprolactone) copolymer (PLC), derivatives and copolymers of poly(amino acid), polyanhydride and polyorthoesters.
250
10. The method according to claim 8, wherein the biodegradable polymer has a weight- average molecular weight ranging from about 5000 g/mol to about 1,000,000 g/mol.
11. The method according to claim 8, wherein the organic solvent is selected from the group consisting of tetrahydrofuran, methylene chloride, chloroform, ethyl acetate, hexafluoroisopropanol and acetone.
12. The method according to claim 8, wherein the biodegradable polymer is used in an amount of about 10 wt % to about 30 wt % based on the weight of the organic solvent.
13. The composition according to claim 8, wherein the biodegradable polymer coating is from about 10 um to about 1mm thick.
265 14. The biodegradable polymer coated copper-T according to claim 8, will release copper ions to the surrounding aqueous medium at a release rate of 10 to 100 micrograms of copper ions per day.
PCT/IN2011/000770 2010-11-08 2011-11-08 A novel intrauterine device with controlled copper release WO2012063262A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU1300384A HU230345B1 (en) 2010-11-08 2011-11-08 Intrauterine device with controlled copper release

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3321/CHE/2010 2010-11-08
IN3321CH2010 2010-11-08

Publications (2)

Publication Number Publication Date
WO2012063262A2 true WO2012063262A2 (en) 2012-05-18
WO2012063262A3 WO2012063262A3 (en) 2012-07-05

Family

ID=45774294

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000770 WO2012063262A2 (en) 2010-11-08 2011-11-08 A novel intrauterine device with controlled copper release

Country Status (4)

Country Link
HU (1) HU230345B1 (en)
PL (1) PL403688A1 (en)
PT (1) PT2012063262W (en)
WO (1) WO2012063262A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014150703A1 (en) * 2013-03-15 2014-09-25 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the genital-rectal areas of the body
US20150065472A1 (en) * 2012-04-23 2015-03-05 Bayer Pharma Aktiengesellschaft Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
US9907691B2 (en) 2013-03-13 2018-03-06 Hologic, Inc. Intrauterine contraceptive devices
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1024660C2 (en) 2003-10-29 2005-05-02 Marc Spits Intrauterine contraceptive device for vaginal insertion comprises an active copper-containing carrier with a coating that releases a hemostatic agent
WO2006108065A2 (en) 2005-04-05 2006-10-12 Elixir Medical Corporation Degradable implantable medical devices
WO2010082197A2 (en) 2009-01-18 2010-07-22 Ilan Bar-Am Novel intra uterine device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5224493A (en) * 1991-01-30 1993-07-06 Cadco Corporation Contraceptive intracervical device and novel nonsystemic agents for the prevention of conception and disease
FI97944C (en) * 1994-07-05 1997-03-25 Leiras Oy Active substance delivery device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1024660C2 (en) 2003-10-29 2005-05-02 Marc Spits Intrauterine contraceptive device for vaginal insertion comprises an active copper-containing carrier with a coating that releases a hemostatic agent
WO2006108065A2 (en) 2005-04-05 2006-10-12 Elixir Medical Corporation Degradable implantable medical devices
WO2010082197A2 (en) 2009-01-18 2010-07-22 Ilan Bar-Am Novel intra uterine device

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
"Mechanisms of the Contraceptive Action of Hormonal Methods and Intrauterine Devices (IUDs", 2006, FAMILY HEALTH INTERNATIONAL
"Progress in Reproductive Health Research", 2002, WORLD HEALTH ORGANIZATION, article "The intrauterine device (IUD)-worth singing about", pages: 1 - 8
DAVID HUBACHER; PAI-LIEN CHEN; SOLA PARK: "Side effects from the copper IUD: do they decrease over time?", CONTRACEPTION, vol. 79, 2009, pages 356 - 362, XP026079962, DOI: doi:10.1016/j.contraception.2008.11.012
JIANJUN ZHU; NAIXIN XU; CHENGDIAN ZHANG: "Characterestics of copper corrosion in simulated uterine fluid in the presence of protein", ADVANCES IN CONTRACEPTION, vol. 15, 1999, pages 179 - 190
JOURNAL CONTRACEPTION, vol. 70, 2004, pages 153 - 157
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B: APPLIED BIOMATERIALS, vol. 80B, no. 1, 2006, pages 220 - 225
KELLER; SARAH: "IUDs Block Fertilization", vol. 16, 1996, NETWORK. FAMILY HEALTH INTERNATIONAL
KJAER A; LAURSEN K; THORMANN L; BORGGARD O; LEBECH P. E: "Copper released from copper intrauterine devices, removed after up to 8 years of use", CONTRACEPTION, vol. 47, 1993, pages 349 - 358
TIMONEN H: "Copper release from copper-T interauterine devices", CONTRACEPTION, vol. 14, no. 1, 1976, pages 25 - 38
ZIELSKE H; KOCH U J; BADURA R; LADEBURG H: "Studies on copper release from copper-T device (T-Cu200) and its influence on sperm migration in vitro", CONTRACEPTION, vol. 10, 1974, pages 651 - 656

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150065472A1 (en) * 2012-04-23 2015-03-05 Bayer Pharma Aktiengesellschaft Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
US9907691B2 (en) 2013-03-13 2018-03-06 Hologic, Inc. Intrauterine contraceptive devices
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
WO2014150703A1 (en) * 2013-03-15 2014-09-25 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the genital-rectal areas of the body
US11857514B2 (en) 2013-03-15 2024-01-02 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11253544B2 (en) 2013-03-15 2022-02-22 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11298316B2 (en) 2013-03-15 2022-04-12 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
AU2014235693B2 (en) * 2013-03-15 2017-10-05 Cda Research Group, Inc. Topical copper ion treatments in the genital-rectal areas of the body
US11717535B2 (en) 2013-03-15 2023-08-08 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11459638B2 (en) 2019-02-22 2022-10-04 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same

Also Published As

Publication number Publication date
PT2012063262W (en) 2015-06-11
PL403688A1 (en) 2014-02-17
HU230345B1 (en) 2016-02-29
HUP1300384A2 (en) 2013-08-28
WO2012063262A3 (en) 2012-07-05
HUP1300384A3 (en) 2013-10-28

Similar Documents

Publication Publication Date Title
WO2012063262A2 (en) A novel intrauterine device with controlled copper release
ES2252962T3 (en) MEDICINAL PRODUCTS WITH DELAYED PHARMACOLOGICAL ACTIVITY, AND PROCEDURE FOR PREPARATION.
EP1357861B1 (en) Spacing device for releasing active substances in the paranasal sinus
EP2905014B1 (en) An intrauterine delivery system for contraception
Quarterman et al. Evolution of drug-eluting biomedical implants for sustained drug delivery
US20080051872A1 (en) Biocorrodible metallic implant having a coating or cavity filling made of a peg/plga copolymer
US11020514B2 (en) Absorbable iron-based alloy medical device implant
JP3771573B2 (en) Bioactive substance release coating with aromatic polymethacrylate
EP3378504B1 (en) Absorbable iron-based alloy implanted medical device and preparation method thereof
US9987115B2 (en) Film encapsulated pelvic implant system and method
EP1496814A2 (en) Resorption-controllable medical implants
EP2111818B1 (en) Intracoronary stent with asymmetric drug releasing controlled coating
JP2010532179A (en) Temporary stiffening mesh prosthesis
US20070100321A1 (en) Medical device
JP2013517086A (en) Biofilm resistant material
KR102004014B1 (en) A drug delivery system
NO139429B (en) INTRAUTERIN PREPARATION DEVICE FOR PEOPLE
Dutra et al. Implantable medical devices and tissue engineering: An overview of manufacturing processes and the use of polymeric matrices for manufacturing and coating their surfaces
EP3419682B1 (en) Crystallization inhibitor compositions for implantable urological devices
Major et al. Implantable drug delivery systems
CN105749345B (en) For be easy to remove implant from separating layer
JP2018520818A (en) Ureteral stent, method and use thereof
US20210378870A1 (en) Multi-functional analgesic-releasing wound dressing
JP7248614B2 (en) Contraceptives and related devices
WO2008042970A2 (en) Chitosan-coated calcium sulfate based medicament delivery system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11822811

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12013500806

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: P.403688

Country of ref document: PL

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11822811

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: PT

Ref legal event code: FG4A

Effective date: 20150605